Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 651 to 660

APOTEX-SILDENAFIL PHT sildenafil (as citrate) 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-SILDENAFIL sildenafil (as citrate) 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-SILDENAFIL sildenafil (as citrate) 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-MYCOPHENOLATE mycophenolate mofetil 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-MONTELUKAST montelukast 10mg (as sodium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-MONTELUKAST montelukast 5 mg (as sodium) chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
EPLERENONE APOTEX, APO-EPLERENONE (Apotex Pty Ltd)

2 August 2018

Prescription medicine registration

Active ingredients: Eplerenone.
TERRY WHITE CHEMISTS OLMESARTAN/AMLODIPINE 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 July 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART OLMESARTAN/AMLODIPINE 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 July 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 62
Page 63
Page 64
Page 65
Current page 66
Page 67
Page 68
Page 69
Page 70
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.